CONFLICTS OF INTEREST
Leukemia, Lymphoma
ONCOLOGY, LEUKEMIA, LYMPHOMA
AM Zeidan: Leukemia and Lymphoma Society Scholar in Clinical Research. Research funding (institutional) from Celgene/BMS, AbbVie, Astex, Pfizer, Medimmune/AstraZeneca, Boehringer‐Ingelheim, Cardiff oncology, Incyte, Takeda, Novartis, Aprea, and ADC Therapeutics. Participated in advisory boards and/or had a consultancy with and received honoraria from AbbVie, Otsuka, Pfizer, Celgene/BMS, Jazz, Incyte, Agios, Boehringer‐Ingelheim, Novartis, Acceleron, Astellas, Daiichi Sankyo, Cardinal Health, Taiho, Seattle Genetics, BeyondSpring, Cardiff Oncology, Takeda, Ionis, Amgen, Janssen, Epizyme, Syndax, Gilead, Kura, Chiesi, ALX Oncology, BioCryst, Notable, Orum, and Tyme. Served on clinical trial committees for Novartis, AbbVie, Gilead, BioCryst, AbbVie, ALX Oncology, Geron, and Celgene/BMS. U Borate: Advisory board for Genentech, Daiichi Sankyo, Takeda, Pfizer, Novartis, Research funding from Novartis, Pfizer, Jazz, Kura Oncology, and Servier. Investigator in AbbVie‐funded Clinical Trials. DA Pollyea: Advisory board member for AbbVie, Jazz, Bristol Myers Squibb, Novartis, BeiGene, BerGenBio, Arcellx, Syros, Immunogen, Astra Zeneca, Notable Labs, Kura, Ryvu; Consultant for Syros, Genentech; Research Funding from Teva, Bristol Myers Squibb, Karyopharm and AbbVie. AM Brunner: Research funding to my institution from Novartis, Celgene, Takeda, AstraZeneca, and consulting for BMS/Celgene, Forty‐Seven, Inc, Gilead, Novartis, Takeda, Keros Therapeutics, Taiho, Agios, AbbVie, and Jazz Pharmaceuticals. F Roncolato: Investigator in AbbVie‐funded Clinical Trials. Jacqueline S Garcia: Institutional research funding (for trials) from AbbVie, Genentech, Pfizer, Prelude, Astra Zeneca; advisory board for AbbVie, Astellas, Takeda. R Filshie: Investigator in AbbVie‐funded Clinical Trials. T Odenike: Consulting or Advisory Role: AbbVie, Celgene; Research Funding: Celgene (Inst), Incyte (Inst), Astra Zeneca, Astex Pharmaceuticals (Inst), NS Pharma (Inst), AbbVie (Inst), Gilead Sciences (Inst), Janssen Oncology (Inst), Oncotherapy (Inst), Agios (Inst), CTI/Baxalta (inst). A‐M Watson: Received Travel Support from Roche, Amgen. R Krishnadasan: Investigator in AbbVie‐funded Clinical Trials. A Bajel: Honoraria—AbbVie, Amgen, Astellas Novartis, Pfizer, Takeda Speaker Fees—Amgen. K Naqvi: Employee of Genentech and may own Roche stock or options. J Zha, WH Cheng, Y Zhou, D Hoffman, JG Harb, J Potluri: Employees of AbbVie and may own stock. G Garcia‐Manero: Research support from Genentech and AbbVie.